Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATE-4: Daclatasvir PK with Atazanavir/Ritonavir vs Atazanavir/Cobicistat
NCT02565888Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cobicistat in hepatitis C (HCV) and human immunodeficiency virus infection (HIV) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area Under the Curve at 24 hours. Started Nov 2015; status: completed.
02
Drugs
cobicistat
03
Conditions
hepatitis C (HCV)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02565888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565888.